ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,346Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 783

$923K Total Retail Price of All Prescriptions

Rank: 62 out of 783

495 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 495 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 495 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 13,110 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 642 536 1 1
FUROSEMIDE 568 478 2 7
SIMVASTATIN 537 402 3 3
HYDROCODONE-ACETAMINOPHEN 444 331 S3 4 2
OMEPRAZOLE 411 282 5 6
AMLODIPINE BESYLATE 381 350 6 5
METOPROLOL TARTRATE 344 289 7 9
METOPROLOL SUCCINATE 310 267 8 13
TRAZODONE HCL 293 215 9 39
LISINOPRIL 292 236 10 4
GABAPENTIN 276 207 11 15
ISOSORBIDE MONONITRATE ER 254 224 12 40
MELOXICAM 247 198 13 37
METFORMIN HCL 240 169 14 8
DONEPEZIL HCL 235 235 15 24
POTASSIUM CHLORIDE 224 194 16 16
TRAMADOL HCL 223 214 17 20
NEXIUM 216 165 18 28
RISPERIDONE 175 158 19 67
AZITHROMYCIN 168 124 20 41
CARVEDILOL 166 122 21 21
PRAVASTATIN SODIUM 165 140 22 14
WARFARIN SODIUM 156 122 23 10
ZOLPIDEM TARTRATE 152 130 24 23
TRIAMTERENE-HCTZ 152 121 24 42
ATORVASTATIN CALCIUM 148 122 26 11
FAMOTIDINE 147 132 27 55
ALLOPURINOL 135 115 28 31
DIVALPROEX SODIUM 133 128 29 72
GLIMEPIRIDE 130 119 30 34
ESCITALOPRAM OXALATE 128 112 31 54
SERTRALINE HCL 125 118 32 22
LANTUS 117 93 33 38
LOSARTAN-HYDROCHLOROTHIAZIDE 114 57 34 53
TAMSULOSIN HCL 114 90 34 26
CLOPIDOGREL 114 90 34 29
NAMENDA 108 95 37 32
ATENOLOL 107 99 38 17
ADVAIR DISKUS 107 76 38 50
FENTANYL 106 105 S2 40 65
LOSARTAN POTASSIUM 104 67 41 18
HYDROCHLOROTHIAZIDE 101 86 42 12
NOVOLOG 91 53 43 81
CITALOPRAM HBR 90 59 44 19
LYRICA 88 47 45 98
POLYETHYLENE GLYCOL 3350 87 66 46 43
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 77 46 95
PLAVIX 87 71 46 51
MIRTAZAPINE 87 85 46 52
CRESTOR 84 58 50 27
CYMBALTA 83 48 51 35
LEVOFLOXACIN 79 68 52 75
COMBIVENT 79 57 52 120
RANITIDINE HCL 78 48 54 44
FLUOXETINE HCL 78 41 54 45
SUCRALFATE 77 53 56 190
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 55 57 33
OXYCODONE-ACETAMINOPHEN 74 53 S2 58 76
NABUMETONE 73 65 59 178
PROAIR HFA 70 52 60 56
CELEBREX 69 56 61 93
LEXAPRO 68 59 62 181
PANTOPRAZOLE SODIUM 68 55 62 30
SPIRONOLACTONE 68 64 62 57
KLOR-CON M10 67 67 65 137
RAMIPRIL 67 54 65 113
SPIRIVA 63 54 67 59
MECLIZINE HCL 63 47 67 146
NITROFURANTOIN 61 59 69 225
LEVEMIR 61 37 69 162
NITROSTAT 60 59 71 191
ONGLYZA 60 60 71 240
METOLAZONE 60 60 71 186
OLANZAPINE 57 39 74 108
CLONIDINE HCL 56 53 75 60
CEPHALEXIN 56 35 75 70
GLYBURIDE-METFORMIN HCL 56 56 R 75 170
DIOVAN 56 40 75 49
TRIAMTERENE-HYDROCHLOROTHIAZID 55 37 79 173
OXYBUTYNIN CHLORIDE ER 55 55 79 117
OXYBUTYNIN CHLORIDE 53 53 81 96
DILTIAZEM 24HR ER 53 53 81 122
LEVETIRACETAM 53 25 81 89
BYSTOLIC 53 53 81 99
QUETIAPINE FUMARATE 52 34 85 79
FLUTICASONE PROPIONATE 51 40 86 46
ENALAPRIL MALEATE 50 50 87 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.